Pascal Jean-Noël Noth

𝖷𝖼𝗎𝖻𝖾.𝖻𝗂𝗈 𝗂𝗌 𝖡𝗂𝗈𝗉𝗁𝖺𝗋𝗆a 𝖬𝖺𝗋𝗄𝖾𝗍-𝖾𝗇𝗍𝗋𝗒 𝖠𝖼𝖼𝖾𝗅𝖾𝗋𝖺𝗍𝗈𝗋 𝖼𝗈𝗆𝗆𝗂𝗍𝗍𝖾𝖽 𝗍𝗈 𝖽𝗂𝗌𝗆𝖺𝗇𝗍𝗅𝗂𝗇𝗀 𝖤𝗎𝗋𝗈𝗉𝖾𝖺𝗇 𝖼𝗈𝗆𝗆𝖾𝗋𝖼𝗂𝖺𝗅 𝖻𝖺𝗋𝗋𝗂𝖾𝗋𝗌 𝗈𝗇𝖾 𝖻𝗒 𝗈𝗇𝖾. 𝖶𝖾 𝗂𝗇𝗏𝖾𝗌𝗍 𝗐𝗂𝗍𝗁 𝖻𝗂𝗈𝗉𝗁𝖺𝗋𝗆𝖺 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗈𝗋𝗌, 𝗍𝗈 𝖼𝗋𝖾𝖺𝗍𝖾 𝗍𝗁𝖾𝗂𝗋 𝗈𝗐𝗇 𝖼𝗈𝗆𝗆𝖾𝗋𝖼𝗂𝖺𝗅 𝖿𝗈𝗈𝗍𝗉𝗋𝗂𝗇𝗍, 𝗈𝗉𝖾𝗋𝖺𝗍𝗂𝗈𝗇𝗌 𝖺𝗇𝖽 𝗋𝖾𝗏𝖾𝗇𝗎𝖾 𝗌𝗍𝗋𝖾𝖺𝗆𝗌. “𝗧𝗼𝗼 𝗰𝗼𝗺𝗽𝗹𝗲𝘅, 𝘁𝗼𝗼 𝗲𝘅𝗽𝗲𝗻𝘀𝗶𝘃𝗲, 𝘁𝗼𝗼 𝘂𝗻𝗰𝗲𝗿𝘁𝗮𝗶𝗻” 𝖳𝗁𝖾𝗌𝖾 𝗐𝗈𝗋𝖽𝗌 𝖾𝖼𝗁𝗈 𝗍𝗁𝗋𝗈𝗎𝗀𝗁 𝖽𝗂𝗌𝖼𝗎𝗌𝗌𝗂𝗈𝗇𝗌 𝗈𝗇 𝗅𝖺𝗎𝗇𝖼𝗁𝗂𝗇𝗀 𝗇𝖾𝗐 𝗍𝗁𝖾𝗋𝖺𝗉𝖾𝗎𝗍𝗂𝖼𝗌 𝗂𝗇 𝖤𝗎𝗋𝗈𝗉𝖾. 𝖨𝗇 𝗍𝗁𝗂𝗌 𝗋𝖾𝗀𝗂𝗈𝗇, 𝗇𝗎𝗆𝖾𝗋𝗈𝗎𝗌 𝖻𝗋𝖾𝖺𝗄𝗍𝗁𝗋𝗈𝗎𝗀𝗁𝗌 𝗋𝖾𝗆𝖺𝗂𝗇 𝗂𝗇𝖺𝖼𝖼𝖾𝗌𝗌𝗂𝖻𝗅𝖾 𝗈𝗋 𝖽𝖾𝗅𝖺𝗒𝖾𝖽, 𝖺𝗇𝖽 𝖼𝗈𝗎𝗇𝗍𝗅𝖾𝗌𝗌 𝗉𝖺𝗍𝗂𝖾𝗇𝗍𝗌 𝖺𝗋𝖾 𝗅𝖾𝖿𝗍 𝗐𝗂𝗍𝗁𝗈𝗎𝗍 𝖺𝖼𝖼𝖾𝗌𝗌 𝗍𝗈 𝖺𝖽𝗏𝖺𝗇𝖼𝖾𝖽 𝗍𝗁𝖾𝗋𝖺𝗉𝗂𝖾𝗌. 𝖱𝖾𝗀𝗋𝖾𝗍𝗍𝖺𝖻𝗅𝗒, 𝗍𝗁𝗂𝗌 𝗀𝖺𝗉 𝖼𝗈𝗇𝗍𝗂𝗇𝗎𝖾𝗌 𝗍𝗈 𝗐𝗂𝖽𝖾𝗇. 𝗕𝘂𝘁 𝘄𝗲 𝘀𝗲𝗲 𝗮 𝘄𝗮𝘆 𝗳𝗼𝗿𝘄𝗮𝗿𝗱. 𝖷𝖼𝗎𝖻𝖾.𝖻𝗂𝗈 𝖾𝗇𝗀𝖺𝗀𝖾𝗌 𝖺 𝖼𝗈𝗆𝖻𝗂𝗇𝖺𝗍𝗂𝗈𝗇 𝗈𝖿 𝖼𝖺𝗉𝗂𝗍𝖺𝗅, 𝗄𝗇𝗈𝗐𝗅𝖾𝖽𝗀𝖾 𝖺𝗇𝖽 𝖽𝖾𝖾𝗉-𝗍𝖾𝖼𝗁 𝖼𝖺𝗉𝖺𝖻𝗂𝗅𝗂𝗍𝗂𝖾𝗌 𝗐𝗋𝖺𝗉𝗉𝖾𝖽 𝗂𝗇𝗍𝗈 𝖺 𝗍𝖾𝗆𝗉𝗈𝗋𝖺𝗋𝗒 𝗅𝖺𝗎𝗇𝖼𝗁 𝗏𝖾𝗁𝗂𝖼𝗅𝖾. 𝖳𝗁𝗂𝗌 𝖺𝗉𝗉𝗋𝗈𝖺𝖼𝗁 𝗆𝗂𝗍𝗂𝗀𝖺𝗍𝖾𝗌 𝗍𝗁𝖾 𝗋𝗂𝗌𝗄𝗌 𝖺𝗌𝗌𝗈𝖼𝗂𝖺𝗍𝖾𝖽 𝗐𝗂𝗍𝗁 𝖺 𝖿𝗂𝗋𝗌𝗍-𝗍𝗂𝗆𝖾 𝗅𝖺𝗎𝗇𝖼𝗁, 𝖺𝗅𝗅 𝗐𝗁𝗂𝗅𝖾 𝗉𝗋𝖾𝗌𝖾𝗋𝗏𝗂𝗇𝗀 𝗍𝗁𝖾 𝗏𝖺𝗅𝗎𝖾 𝖺𝗇𝖽 𝖼𝗈𝗇𝗍𝗋𝗈𝗅 𝗈𝖿 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗈𝗋𝗌. 𝖫𝗂𝗇𝗄𝗂𝗇𝗀 𝖡𝗂𝗈𝗉𝗁𝖺𝗋𝗆𝖺 𝖵𝗂𝗌𝗂𝗈𝗇𝖺𝗋𝗂𝖾𝗌 𝗐𝗂𝗍𝗁 𝖯𝖺𝗍𝗂𝖾𝗇𝗍𝗌. 𝗝𝗼𝗶𝗻 𝘁𝗵𝗲 𝗰𝘂𝗯𝗲.

SERB is a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. SERB began in the 1950s as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research). Today SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. Improving patients’ quality of life and offering hope is what motivates and inspires us. For employees, SERB is a dynamic organisation where you can expand your skills and explore new challenges. We invest in the development of all of our people and offer opportunities for advancement that allow talented employees to grow with us. Our employees that come from all walks of life. They offer a diversity of opinions and perspective that we believe leads to better business decisions and more innovative solutions to problems. We foster an open and inclusive environment that demands mutual respect and allows employees to understand each other and learn from each other’s experiences

Founded in 1980, MIR specializes in the fabrication and distribution of lightweight conveyor belting and industrial conveyor products. We focus on providing value-added products and services through all our full service sales and fabrication facilities located across the United States, with our corporate headquarters located in St. Louis, Missouri. With highly-trained technicians available 24/7 for field installations and a staff with more than 1,500 aggregate years of belting experience, MIR has earned a reputation as the premier independent specialty fabricator and distributor of lightweight belting and conveyor accessories in North America. Mission Statement Our mission is to enhance MIR’s market leadership position by creating an open environment of partnership with employees and suppliers to best service our customers. Vision Statement We believe in making business an enjoyable, hassle-free experience for our customers. There is no such thing as an unreasonable request. We will create expectations for our customers and exceed them at every opportunity. Our order will be delivered on time, every time, to the best of our ability. We believe that quality products are a result of quality people. Every employee will be treated with trust and respect. Every employee will be dedicated to doing the job right for the customer in a safe, enthusiastic and productive manner. We encourage risk taking and tolerate mistakes as long as we can learn from them. We are not satisfied with mediocrity and status quo. We are in the business of providing world-class products and services to our customers. We have a responsibility to our employees, our stakeholders, and ultimately to our customers, to be recognized as the highest valued supplier.

AMMEGA is a global company located in 40 countries. We value our employees, customers, entrepreneurship and we act in an agile and responsible way. Our mission and continuous improvement culture are the foundation for a solid and sustainable business appreciated by our customers. The AMMEGA Groups businesses provide advanced and high-quality belting solutions for 20 different industries including global logistics, food production, fitness equipment, household appliances and energy production. Our global network of about 6000 employees, being a part of a high-performance organization, develop their careers in a global environment, participate in diverse teams, and take advantage of our worldwide expertise in conveyor belting, power transmission, fluid power and business services. AMMEGA’s sustainable business approach ensures our teams operate within a safe and stable work environment, with high respect for their professional development and well-being.

Loyalty Partner is one of the leading international providers of loyalty management solutions, operates multi-partner programmes and supplies its clients with performance marketing solutions through PAYBACK. Loyalty Partner has a workforce of 600 employees. The company is headquartered in Munich, with subsidiaries in the United States, India, the United Kingdom, France, Spain and Poland. Loyalty Partner is the centre of expertise for marketing and couponing platforms within the American Express Group.

Dress for Less is Europes leading online designer fashion outlet. Founded in 1999, it is since 2011 part of the online retail group Privalia. Dress for Less is present in over 50 countries worldwide, and is headquartered in Frankfurt am Main, Germany.

Since 1952, Cambridge Education Group has been delivering the highest quality academic programmes, providing a valuable stepping-stone for thousands of students to progress onto the worlds leading universities and maximise their career opportunities. Whether students choose to study at one of our centres with OnCampus or Castel or complete an online programme with CEG Digital or iheed, Cambridge Education Group promises to help students Achieve More with expert tutors, innovative high-quality content, premium facilities, and the personal service our students deserve.

United Accountants is building a national network of independently led CPA firms. We acquire and partner with established practices, offering fair market multiples, flexible succession options, and committed capital. Our model preserves each firm’s identity, team, and client relationships while adding operational expertise, modern technology, and shared resources to improve margins and unlock growth. For some owners, that means a smooth exit. For others, it’s a chance to stay on, keep equity, and scale with our support.

Opera is a private equity platform focused on backing Independent Sponsor co-investments in Europe. The firm targets strategies requiring specialist domain expertise and where transactional, operational and strategic value creation levers combine to drive outperformance. Opera has >EUR 300 million AUM and is backed by a consortium of institutional investors, including pension funds, foundations and family offices. The firm is currently investing its third fund vehicle.

𝖷𝖼𝗎𝖻𝖾.𝖻𝗂𝗈 𝗂𝗌 𝖡𝗂𝗈𝗉𝗁𝖺𝗋𝗆a 𝖬𝖺𝗋𝗄𝖾𝗍-𝖾𝗇𝗍𝗋𝗒 𝖠𝖼𝖼𝖾𝗅𝖾𝗋𝖺𝗍𝗈𝗋 𝖼𝗈𝗆𝗆𝗂𝗍𝗍𝖾𝖽 𝗍𝗈 𝖽𝗂𝗌𝗆𝖺𝗇𝗍𝗅𝗂𝗇𝗀 𝖤𝗎𝗋𝗈𝗉𝖾𝖺𝗇 𝖼𝗈𝗆𝗆𝖾𝗋𝖼𝗂𝖺𝗅 𝖻𝖺𝗋𝗋𝗂𝖾𝗋𝗌 𝗈𝗇𝖾 𝖻𝗒 𝗈𝗇𝖾. 𝖶𝖾 𝗂𝗇𝗏𝖾𝗌𝗍 𝗐𝗂𝗍𝗁 𝖻𝗂𝗈𝗉𝗁𝖺𝗋𝗆𝖺 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗈𝗋𝗌, 𝗍𝗈 𝖼𝗋𝖾𝖺𝗍𝖾 𝗍𝗁𝖾𝗂𝗋 𝗈𝗐𝗇 𝖼𝗈𝗆𝗆𝖾𝗋𝖼𝗂𝖺𝗅 𝖿𝗈𝗈𝗍𝗉𝗋𝗂𝗇𝗍, 𝗈𝗉𝖾𝗋𝖺𝗍𝗂𝗈𝗇𝗌 𝖺𝗇𝖽 𝗋𝖾𝗏𝖾𝗇𝗎𝖾 𝗌𝗍𝗋𝖾𝖺𝗆𝗌. “𝗧𝗼𝗼 𝗰𝗼𝗺𝗽𝗹𝗲𝘅, 𝘁𝗼𝗼 𝗲𝘅𝗽𝗲𝗻𝘀𝗶𝘃𝗲, 𝘁𝗼𝗼 𝘂𝗻𝗰𝗲𝗿𝘁𝗮𝗶𝗻” 𝖳𝗁𝖾𝗌𝖾 𝗐𝗈𝗋𝖽𝗌 𝖾𝖼𝗁𝗈 𝗍𝗁𝗋𝗈𝗎𝗀𝗁 𝖽𝗂𝗌𝖼𝗎𝗌𝗌𝗂𝗈𝗇𝗌 𝗈𝗇 𝗅𝖺𝗎𝗇𝖼𝗁𝗂𝗇𝗀 𝗇𝖾𝗐 𝗍𝗁𝖾𝗋𝖺𝗉𝖾𝗎𝗍𝗂𝖼𝗌 𝗂𝗇 𝖤𝗎𝗋𝗈𝗉𝖾. 𝖨𝗇 𝗍𝗁𝗂𝗌 𝗋𝖾𝗀𝗂𝗈𝗇, 𝗇𝗎𝗆𝖾𝗋𝗈𝗎𝗌 𝖻𝗋𝖾𝖺𝗄𝗍𝗁𝗋𝗈𝗎𝗀𝗁𝗌 𝗋𝖾𝗆𝖺𝗂𝗇 𝗂𝗇𝖺𝖼𝖼𝖾𝗌𝗌𝗂𝖻𝗅𝖾 𝗈𝗋 𝖽𝖾𝗅𝖺𝗒𝖾𝖽, 𝖺𝗇𝖽 𝖼𝗈𝗎𝗇𝗍𝗅𝖾𝗌𝗌 𝗉𝖺𝗍𝗂𝖾𝗇𝗍𝗌 𝖺𝗋𝖾 𝗅𝖾𝖿𝗍 𝗐𝗂𝗍𝗁𝗈𝗎𝗍 𝖺𝖼𝖼𝖾𝗌𝗌 𝗍𝗈 𝖺𝖽𝗏𝖺𝗇𝖼𝖾𝖽 𝗍𝗁𝖾𝗋𝖺𝗉𝗂𝖾𝗌. 𝖱𝖾𝗀𝗋𝖾𝗍𝗍𝖺𝖻𝗅𝗒, 𝗍𝗁𝗂𝗌 𝗀𝖺𝗉 𝖼𝗈𝗇𝗍𝗂𝗇𝗎𝖾𝗌 𝗍𝗈 𝗐𝗂𝖽𝖾𝗇. 𝗕𝘂𝘁 𝘄𝗲 𝘀𝗲𝗲 𝗮 𝘄𝗮𝘆 𝗳𝗼𝗿𝘄𝗮𝗿𝗱. 𝖷𝖼𝗎𝖻𝖾.𝖻𝗂𝗈 𝖾𝗇𝗀𝖺𝗀𝖾𝗌 𝖺 𝖼𝗈𝗆𝖻𝗂𝗇𝖺𝗍𝗂𝗈𝗇 𝗈𝖿 𝖼𝖺𝗉𝗂𝗍𝖺𝗅, 𝗄𝗇𝗈𝗐𝗅𝖾𝖽𝗀𝖾 𝖺𝗇𝖽 𝖽𝖾𝖾𝗉-𝗍𝖾𝖼𝗁 𝖼𝖺𝗉𝖺𝖻𝗂𝗅𝗂𝗍𝗂𝖾𝗌 𝗐𝗋𝖺𝗉𝗉𝖾𝖽 𝗂𝗇𝗍𝗈 𝖺 𝗍𝖾𝗆𝗉𝗈𝗋𝖺𝗋𝗒 𝗅𝖺𝗎𝗇𝖼𝗁 𝗏𝖾𝗁𝗂𝖼𝗅𝖾. 𝖳𝗁𝗂𝗌 𝖺𝗉𝗉𝗋𝗈𝖺𝖼𝗁 𝗆𝗂𝗍𝗂𝗀𝖺𝗍𝖾𝗌 𝗍𝗁𝖾 𝗋𝗂𝗌𝗄𝗌 𝖺𝗌𝗌𝗈𝖼𝗂𝖺𝗍𝖾𝖽 𝗐𝗂𝗍𝗁 𝖺 𝖿𝗂𝗋𝗌𝗍-𝗍𝗂𝗆𝖾 𝗅𝖺𝗎𝗇𝖼𝗁, 𝖺𝗅𝗅 𝗐𝗁𝗂𝗅𝖾 𝗉𝗋𝖾𝗌𝖾𝗋𝗏𝗂𝗇𝗀 𝗍𝗁𝖾 𝗏𝖺𝗅𝗎𝖾 𝖺𝗇𝖽 𝖼𝗈𝗇𝗍𝗋𝗈𝗅 𝗈𝖿 𝗂𝗇𝗇𝗈𝗏𝖺𝗍𝗈𝗋𝗌. 𝖫𝗂𝗇𝗄𝗂𝗇𝗀 𝖡𝗂𝗈𝗉𝗁𝖺𝗋𝗆𝖺 𝖵𝗂𝗌𝗂𝗈𝗇𝖺𝗋𝗂𝖾𝗌 𝗐𝗂𝗍𝗁 𝖯𝖺𝗍𝗂𝖾𝗇𝗍𝗌. 𝗝𝗼𝗶𝗻 𝘁𝗵𝗲 𝗰𝘂𝗯𝗲.

At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether youre in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare.

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®). Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Find out more: www.sterlingpharmasolutions.com/sterling-facilities